Back to Search
Start Over
Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population
- Source :
- Circulation. Cardiovascular Genetics
- Publication Year :
- 2017
-
Abstract
- Supplemental Digital Content is available in the text.<br />Background— Cardiomyocytes secrete atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) in response to mechanical stretching, making them useful clinical biomarkers of cardiac stress. Both human and animal studies indicate a role for ANP as a regulator of blood pressure with conflicting results for BNP. Methods and Results— We used genome-wide association analysis (n=6296) to study the effects of genetic variants on circulating natriuretic peptide concentrations and compared the impact of natriuretic peptide–associated genetic variants on blood pressure (n=27 059). Eight independent genetic variants in 2 known (NPPA-NPPB and POC1B-GALNT4) and 1 novel locus (PPP3CC) associated with midregional proANP (MR-proANP), BNP, aminoterminal proBNP (NT-proBNP), or BNP:NT-proBNP ratio. The NPPA-NPPB locus containing the adjacent genes encoding ANP and BNP harbored 4 independent cis variants with effects specific to either midregional proANP or BNP and a rare missense single nucleotide polymorphism in NT-proBNP seriously altering its measurement. Variants near the calcineurin catalytic subunit gamma gene PPP3CC and the polypeptide N-acetylgalactosaminyltransferase 4 gene GALNT4 associated with BNP:NT-proBNP ratio but not with BNP or midregional proANP, suggesting effects on the post-translational regulation of proBNP. Out of the 8 individual variants, only those correlated with midregional proANP had a statistically significant albeit weak impact on blood pressure. The combined effect of these 3 single nucleotide polymorphisms also associated with hypertension risk (P=8.2×10−4). Conclusions— Common genetic differences affecting the circulating concentration of ANP associated with blood pressure, whereas those affecting BNP did not, highlighting the blood pressure–lowering effect of ANP in the general population.
- Subjects :
- 0301 basic medicine
Male
Genome-wide association study
Blood Pressure
030204 cardiovascular system & hematology
Mechanical stretching
DISEASE
Cohort Studies
0302 clinical medicine
Atrial natriuretic peptide
Natriuretic Peptide, Brain
Natriuretic peptide
Medicine
Myocytes, Cardiac
genes
Genetics (clinical)
Finland
TRANSGENIC MICE
RISK
education.field_of_study
blood pressure
Middle Aged
3. Good health
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING
cardiovascular system
HEART-FAILURE
Female
Cardiology and Cardiovascular Medicine
hormones, hormone substitutes, and hormone antagonists
Atrial Natriuretic Factor
circulatory and respiratory physiology
Genetically modified mouse
Adult
medicine.medical_specialty
hypertension
medicine.drug_class
brain
Population
Article
CLONING
03 medical and health sciences
Internal medicine
Genetics
Humans
cardiovascular diseases
education
Aged
genome-wide association study
natriuretic peptide
business.industry
ta1184
Genetic Variation
DNA
Original Articles
ta3121
medicine.disease
MODEL
030104 developmental biology
Endocrinology
Blood pressure
3121 General medicine, internal medicine and other clinical medicine
Heart failure
3111 Biomedicine
business
Genome-Wide Association Study
Subjects
Details
- ISSN :
- 19423268
- Volume :
- 10
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Circulation. Cardiovascular genetics
- Accession number :
- edsair.doi.dedup.....f3d1b8253789596ca389b334ea9b7d4f